These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 19416615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Facilitatory and inhibitory effects of SCN5A mutations on atrial fibrillation in Brugada syndrome.
    Amin AS, Boink GJ, Atrafi F, Spanjaart AM, Asghari-Roodsari A, Molenaar RJ, Ruijter JM, Wilde AA, Tan HL.
    Europace; 2011 Jul; 13(7):968-75. PubMed ID: 21273195
    [Abstract] [Full Text] [Related]

  • 6. Channelopathies: a new category of diseases causing sudden death.
    Brugada J, Brugada R, Brugada P.
    Herz; 2007 May; 32(3):185-91. PubMed ID: 17497250
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome.
    Lombardi F, Potenza S, Beltrami A, Verzoni A, Brugada P, Brugada R.
    J Cardiovasc Med (Hagerstown); 2007 Mar; 8(3):201-4. PubMed ID: 17312439
    [Abstract] [Full Text] [Related]

  • 12. Sudden cardiac death and inherited arrhythmia syndromes.
    Sarkozy A, Brugada P.
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S8-20. PubMed ID: 16138889
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T, Surber R.
    Prog Biophys Mol Biol; 2008 Sep; 98(2-3):120-36. PubMed ID: 19027780
    [Abstract] [Full Text] [Related]

  • 15. Clinical aspects and physiopathology of Brugada syndrome: review of current concepts.
    Herbert E, Chahine M.
    Can J Physiol Pharmacol; 2006 Sep; 84(8-9):795-802. PubMed ID: 17111025
    [Abstract] [Full Text] [Related]

  • 16. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE, Viswanathan PC, Weiss R, Shang LL, Sanyal S, Shusterman V, Kornblit C, London B, Dudley SC.
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural heart disease, SCN5A gene mutations, and Brugada syndrome: a complex ménage à trois.
    Saffitz JE.
    Circulation; 2005 Dec 13; 112(24):3672-4. PubMed ID: 16344397
    [No Abstract] [Full Text] [Related]

  • 20. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
    Smits JP, Blom MT, Wilde AA, Tan HL.
    Expert Opin Pharmacother; 2008 Mar 13; 9(4):537-49. PubMed ID: 18312156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.